Thermo Fisher Scientific Inc. and Gentel Biosciences have completed the first stage of a collaboration to shift microarrays to a new 96-well configuration. This new product will move the current microarray offerings toward an ELISA-like format to increase the speed and volume of multiplex applications. The new platform conforms to the SBS microplate standard.
Thermo Fisher Scientific offers the platform under the Thermo Scientific SmartPlex brand name, with a range of microarray chemistry configurations including aminosilane and epoxysilane. Gentel Biosciences offers the platform engineered with a proprietary ultra-thin nitrocellulose surface chemistry under the APiX96 brand name. Gentel has also initiated development of content-based research kits including quantitative multiplex immunoassays, antibody and antigen arrays in the 96-well format.
www.gentelbio.com
www.thermofisher.com
This article was published in Drug Discovery & Development magazine: Vol. 11, No. 8, August, 2008, pp. 26.
Filed Under: Genomics/Proteomics
![A display of DNA sequencing output from an automated ABI 373 sequencer. [National Human Genome Research Institute (NHGRI)]](https://www.drugdiscoverytrends.com/wp-content/uploads/2024/06/51187236177_b7b566a401_k-268x170.jpg)
